期刊
THROMBOSIS RESEARCH
卷 126, 期 3, 页码 238-242出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.thromres.2010.06.025
关键词
Myeloproliferative neoplasms; Circulating procoagulant activity; Thrombin generation; Thrombomodulin resistance
资金
- La Ligue contre le Cancer
- Institut National du Cancer (INCa)
Microparticles (MPs) are membrane fragments ranging in size from 0.1 to 1 mu m, and are considered as biomarkers reflecting prothrombotic state in many clinical diseases. The clinical course of myeloproliferative neoplasms (MPN) being frequently complicated by thrombotic events, we determined the MPs activity, i.e. circulating procoagulant activity (CPA), in polycythemia vera (PV) and essential thrombocythemia (ET) patients. To evaluate the influence of MPs on the coagulation, a thrombin generation test was realized in the absence and presence of thrombomodulin (TM). Compared with controls, patients had a higher CPA (24.0 +/- 9.0 vs 10.6 +/- 4.4 nM, p<0.001), which was associated with a lower inhibition of the thrombin generation in the presence of TM (20.1 +/- 9.5% vs 28.4 +/- 11.8%, p<0.001), compatible with a low sensitivity to TM. This sensitivity was influenced by the JAK2V617F mutational status, homozygous patients presenting the lowest inhibition rate of the thrombin generation. Filtration through a 0.22 mu m membrane increased the sensitivity to TM in plasma, suggesting an influence of MPs in the TM-resistance observed in patients. Moreover, MPN patients receiving antiplatelet and/or cytoreductive therapies, our study suggests that CPA might be influenced by cytoreductive therapy. In conclusion, our data evidence in MPN patients the occurrence of an acquired TM-resistance partly determined by circulating microparticles. This TM-resistance might contribute to the hypercoagulable state observed in MPN patients, but the predictive value of the TM-resistance for thrombosis had not been evaluated. (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据